Head and Neck Cancer in Children: A Retrospective Study
Launched by ASSIUT UNIVERSITY · Sep 21, 2015
Trial Information
Current as of June 27, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying head and neck cancer in children to better understand how different types of these cancers affect young patients. The researchers want to gather information about the characteristics of the tumors, where they commonly occur, and how well patients respond to treatment. The study is being conducted at the South Egypt Cancer Institute, which is a major center for cancer care in Upper Egypt.
To participate in this trial, patients must be under 19 years old and diagnosed with a primary malignant tumor in the head and neck area. Unfortunately, patients over 18 or those with certain types of cancer, like those starting in the bone marrow or central nervous system, cannot participate. If eligible, participants can expect to share their medical history and treatment experiences, which will help doctors learn more about these cancers and improve future care for young patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients whose age less than 19 years.
- • Patients diagnosed with a primary malignant tumor of the head \& neck.
- Exclusion Criteria:
- • Patients whose age more than 18 years.
- • Patients diagnosed with a malignant disease primarily arising from the bone marrow.
- • Patients diagnosed with tumors of the central nervous system.
- • Patients diagnosed with retinoblastoma.
About Assiut University
Assiut University, a prominent academic institution located in Egypt, is dedicated to advancing medical research and clinical trials that enhance healthcare outcomes. With a strong emphasis on innovation and collaboration, the university engages in a wide array of clinical studies across various disciplines, aiming to contribute valuable insights into disease prevention, diagnosis, and treatment. Assiut University's commitment to ethical research practices and rigorous scientific methodology ensures the integrity and reliability of its clinical trials, ultimately benefiting both the local community and the global medical landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Assiut, , Egypt
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials